Geographic differences seen, with notable rises in the Midwest and Southeast<\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
THURSDAY, Dec. 23, 2021 (HealthDay News) — The incidence of oropharyngeal cancer (OPC) continues to increase nationally among U.S. men, according to a study published online Dec. 16 i<\/em>n JAMA Otolaryngology-Head & Neck Surgery<\/em>.<\/p>\n Haluk Damgacioglu, Ph.D., from UTHealth Science Center at Houston, and colleagues used the U.S. Cancer Statistics dataset to examine OPC incidence trends from 2001 through 2017. <\/p>\n The researchers found that nationally, there were 260,182 OPC cases, with 80 percent occurring in men, 65 percent at a regional stage, and 55 percent occurring in the Southeast and Midwest regions. Among men, the incidence of OPC increased nationally 2.7 percent per year, particularly among non-Hispanic White men and in men ages 65 years and older (more than 3 percent per year). Additionally, the most pronounced increases were clustered in the Southeast and Midwest regions (>3.5 percent per year). Among women, the annual percentage change was 0.5 percent. Among men, regional-stage OPC incidence increased nearly twofold versus 1.0 percent per year in women. OPC incidence-based mortality increased among men 2.1 percent per year from 2006 to 2017, while there was a 1.2 percent decrease in women.<\/p>\n “The notable rise in regional-stage OPC and the concurrent recent rise in mortality among men is troubling and calls for urgent improvements in prevention,” the authors write.<\/p>\n One author disclosed financial ties to the pharmaceutical industry.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n Editorial (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n